US

Patrick Deluca

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Deluca. Retrieved from https://idiyas.com/inventor/patrick-deluca-pir7x55o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Patrick Deluca: Innovator in Pharmaceutical Delivery Systems

Introduction

Patrick Deluca is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical formulations, particularly in improving the delivery of therapeutic agents. His innovative approach focuses on enhancing the solubility and effectiveness of medications.

Latest Patents

Patrick Deluca holds a notable patent titled "Co-Solvent Compositions And Methods For Improved Delivery Of Dantrolene Therapeutic Agents." This invention provides methods for using terf-butyl alcohol (TBA) co-solvent systems in the formulation and production of pharmaceutical agents with low solubility. The patent outlines a method for creating a dantrolene sodium (DS) formulation for intravenous use, which represents a significant advancement in the pharmacotherapy of patients experiencing malignant hyperthermia during surgery.

Career Highlights

Throughout his career, Patrick has focused on developing innovative solutions that address critical challenges in the pharmaceutical industry. His work has led to advancements that improve patient outcomes and enhance the efficacy of treatments.

Collaborations

Patrick has collaborated with notable colleagues, including Ahmad Malkawi and Abeer M Al-Ghananeem. These partnerships have contributed to the development of his innovative pharmaceutical solutions.

Conclusion

Patrick Deluca is a dedicated inventor whose work in pharmaceutical delivery systems has the potential to transform patient care. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…